R&D Systems™ Recombinant Mouse IL-21 Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Mouse IL-21 Protein is derived from E. coli. The Recombinant Mouse IL-21 Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: Q9ES17.1
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein. *1 mg pack size (01M) is supplied as a 0.2 μm filtered solution in PBS with BSA as a carrier protein.
• Gene ID (Entrez): 59067
• Molecular Weight (g/mol): 14.4 kDa
• Quantity: 25 μg
• Source: <EM>E. coli</EM>-derived mouse IL-21 protein Pro25-Ser146, with and without an N-terminal Met
• Storage Requirements: Manual defrost freezer; Avoid repeated freeze-thaw cycles; 12 mo. from receipt, -20 to -70°C as supplied; 1 mo, 2 to 8°C under sterile conditions after reconstitution; 3 mo, -20 to -70°C under sterile conditions after reconstitution
• Regulatory Status: RUO
• Endotoxin Concentration: <0.01 EU per 1 μg of the protein by the LAL method.
• Gene Symbol: Il21
• Conjugate: Unconjugated
• Cross Reactivity: IL-21
• Species: Mouse
• Reconstitution: Reconstitute at 100 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin.
• Purity or Quality Grade: >97%, by SDS-PAGE under reducing conditions and visualized by silver stain.